These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Possible involvement of hydroxyl radical on the stimulation of tetrahydrobiopterin synthesis by hydrogen peroxide and peroxynitrite in vascular endothelial cells. Shimizu S; Ishii M; Miyasaka Y; Wajima T; Negoro T; Hagiwara T; Kiuchi Y Int J Biochem Cell Biol; 2005 Apr; 37(4):864-75. PubMed ID: 15694845 [TBL] [Abstract][Full Text] [Related]
26. Induction of tetrahydrobiopterin synthesis in human umbilical vein smooth muscle cells by inflammatory stimuli. Walter R; Linscheid P; Blau N; Kierat L; Schaffner A; Schoedon G Immunol Lett; 1998 Jan; 60(1):13-7. PubMed ID: 9541457 [TBL] [Abstract][Full Text] [Related]
27. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. Werner-Felmayer G; Werner ER; Fuchs D; Hausen A; Reibnegger G; Schmidt K; Weiss G; Wachter H J Biol Chem; 1993 Jan; 268(3):1842-6. PubMed ID: 7678411 [TBL] [Abstract][Full Text] [Related]
28. Protective effects of tetrahydrobiopterin against nitric oxide-induced endothelial cell death. Shimizu S; Ishii M; Kawakami Y; Momose K; Yamamoto T Life Sci; 1998; 63(18):1585-92. PubMed ID: 9806211 [TBL] [Abstract][Full Text] [Related]
29. Effects of activating and deactivating cytokines on the functionally linked tetrahydrobiopterin. No pathways in vascular smooth muscle cells. Walter R; Blau N; Kierat L; Schaffner A; Schoedon G Immunol Lett; 1996 Dec; 54(1):25-9. PubMed ID: 9030978 [TBL] [Abstract][Full Text] [Related]
31. Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production. Gross SS; Levi R; Madera A; Park KH; Vane J; Hattori Y Adv Exp Med Biol; 1993; 338():295-300. PubMed ID: 7508166 [TBL] [Abstract][Full Text] [Related]
33. Inhalation of the nitric oxide synthase cofactor tetrahydrobiopterin in healthy volunteers. Walter R; Blau N; Schaffner A; Schneemann M; Speich R; Stocker R; Naujeck B; Schoedon G Am J Respir Crit Care Med; 1997 Dec; 156(6):2006-10. PubMed ID: 9412588 [TBL] [Abstract][Full Text] [Related]
34. Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Cunnington C; Van Assche T; Shirodaria C; Kylintireas I; Lindsay AC; Lee JM; Antoniades C; Margaritis M; Lee R; Cerrato R; Crabtree MJ; Francis JM; Sayeed R; Ratnatunga C; Pillai R; Choudhury RP; Neubauer S; Channon KM Circulation; 2012 Mar; 125(11):1356-66. PubMed ID: 22315282 [TBL] [Abstract][Full Text] [Related]
35. Regulation of 6-pyruvoyltetrahydropterin synthase activity and messenger RNA abundance in human vascular endothelial cells. Linscheid P; Schaffner A; Blau N; Schoedon G Circulation; 1998 Oct; 98(17):1703-6. PubMed ID: 9788822 [TBL] [Abstract][Full Text] [Related]
36. Stay in Shape With BH4: Loss of Endothelial Tetrahydrobiopterin Promotes Aortic Aneurysm Development in Mice. Brandes RP Hypertension; 2018 Jul; 72(1):61-62. PubMed ID: 29844147 [No Abstract] [Full Text] [Related]
37. Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. Katusic ZS; d'Uscio LV; Nath KA Trends Pharmacol Sci; 2009 Jan; 30(1):48-54. PubMed ID: 19042039 [TBL] [Abstract][Full Text] [Related]
39. Delivery of exogenous tetrahydrobiopterin (BH4) to cells of target organs: role of salvage pathway and uptake of its precursor in effective elevation of tissue BH4. Hasegawa H; Sawabe K; Nakanishi N; Wakasugi OK Mol Genet Metab; 2005 Dec; 86 Suppl 1():S2-10. PubMed ID: 16256391 [TBL] [Abstract][Full Text] [Related]
40. Modulation of nitric oxide synthase activity in intact cells by intracellular tetrahydrobiopterin levels. Werner-Felmayer G; Werner ER; Weiss G; Wachter H Adv Exp Med Biol; 1993; 338():309-12. PubMed ID: 7508169 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]